These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38259623)

  • 21. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.
    Taylor MR; Fain PR; Sinagra G; Robinson ML; Robertson AD; Carniel E; Di Lenarda A; Bohlmeyer TJ; Ferguson DA; Brodsky GL; Boucek MM; Lascor J; Moss AC; Li WL; Stetler GL; Muntoni F; Bristow MR; Mestroni L;
    J Am Coll Cardiol; 2003 Mar; 41(5):771-80. PubMed ID: 12628721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.
    Bilińska ZT; Sylvius N; Grzybowski J; Fidziańska A; Michalak E; Walczak E; Walski M; Bieganowska K; Szymaniak E; Kuśmierczyk-Droszcz B; Lubiszewska B; Wagner T; Tesson F; Ruzyłło W
    Kardiol Pol; 2006 Aug; 64(8):812-9; discussion 820-1. PubMed ID: 16981056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype Complements the Phenotype: Identification of the Pathogenicity of an LMNA Splice Variant by Nanopore Long-Read Sequencing in a Large DCM Family.
    Sedaghat-Hamedani F; Rebs S; Kayvanpour E; Zhu C; Amr A; Müller M; Haas J; Wu J; Steinmetz LM; Ehlermann P; Streckfuss-Bömeke K; Frey N; Meder B
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy.
    Jansweijer JA; Nieuwhof K; Russo F; Hoorntje ET; Jongbloed JD; Lekanne Deprez RH; Postma AV; Bronk M; van Rijsingen IA; de Haij S; Biagini E; van Haelst PL; van Wijngaarden J; van den Berg MP; Wilde AA; Mannens MM; de Boer RA; van Spaendonck-Zwarts KY; van Tintelen JP; Pinto YM
    Eur J Heart Fail; 2017 Apr; 19(4):512-521. PubMed ID: 27813223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic identification of putative biomarkers for early detection of sudden cardiac death in a family with a LMNA gene mutation causing dilated cardiomyopathy.
    Izquierdo I; Rosa I; Bravo SB; Guitián E; Pérez-Serra A; Campuzano O; Brugada R; Mangas A; García Á; Toro R
    J Proteomics; 2016 Oct; 148():75-84. PubMed ID: 27457270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of the aging related LMNA splice variant progerin in dilated cardiomyopathy.
    Messner M; Ghadge SK; Goetsch V; Wimmer A; Dörler J; Pölzl G; Zaruba MM
    PLoS One; 2018; 13(4):e0196739. PubMed ID: 29702688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction.
    Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel deletion mutation accompanied by a point mutation in Lamin A/C gene: Screened from a dilated cardiomyopathy family.
    Jia H; Sun Y; Yao W; Chen Z; Yang S; Wang C; Lu S
    Perfusion; 2023 May; 38(4):826-836. PubMed ID: 35514053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laminopathies: a Pandora's box of heart failure, bradyarrhythmias and sudden death.
    Cabanelas N; Martins VP
    Rev Port Cardiol; 2015 Feb; 34(2):139.e1-5. PubMed ID: 25656816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
    Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
    Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum lipidomics meets cardiac magnetic resonance imaging: profiling of subjects at risk of dilated cardiomyopathy.
    Sysi-Aho M; Koikkalainen J; Seppänen-Laakso T; Kaartinen M; Kuusisto J; Peuhkurinen K; Kärkkäinen S; Antila M; Lauerma K; Reissell E; Jurkko R; Lötjönen J; Heliö T; Orešič M
    PLoS One; 2011 Jan; 6(1):e15744. PubMed ID: 21283746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.
    Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D
    J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.
    Sébillon P; Bouchier C; Bidot LD; Bonne G; Ahamed K; Charron P; Drouin-Garraud V; Millaire A; Desrumeaux G; Benaïche A; Charniot JC; Schwartz K; Villard E; Komajda M
    J Med Genet; 2003 Aug; 40(8):560-7. PubMed ID: 12920062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of cardiac involvement in children with
    Cesar S; Campuzano O; Cruzalegui J; Fiol V; Moll I; Martínez-Barrios E; Zschaeck I; Natera-de Benito D; Ortez C; Carrera L; Expósito J; Berrueco R; Bautista-Rodriguez C; Dabaj I; Gómez García-de-la-Banda M; Quijano-Roy S; Brugada J; Nascimento A; Sarquella-Brugada G
    Front Cell Dev Biol; 2023; 11():1142937. PubMed ID: 36968203
    [No Abstract]   [Full Text] [Related]  

  • 35. A Novel Truncating LMNA Mutation in Patients with Cardiac Conduction Disorders and Dilated Cardiomyopathy.
    Kawakami H; Ogimoto A; Tokunaga N; Nishimura K; Kawakami H; Higashi H; Iio C; Kono T; Aono J; Uetani T; Nagai T; Inoue K; Suzuki J; Ikeda S; Okura T; Ohyagi Y; Tabara Y; Higaki J
    Int Heart J; 2018 May; 59(3):531-541. PubMed ID: 29628476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laminopathies: should Wenckebach be a cause for concern? A case report.
    Sen G; Jackson T
    Eur Heart J Case Rep; 2021 Nov; 5(11):ytab331. PubMed ID: 34816081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a new lamin A/C mutation in a Chinese family affected with atrioventricular block as the prominent phenotype.
    Wu X; Wang QK; Gui L; Liu M; Zhang X; Jin R; Li W; Yan L; Du R; Wang Q; Zhu J; Yang J
    J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):103-7. PubMed ID: 20155465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the Crosstalk Between
    Zahr HC; Jaalouk DE
    Front Genet; 2018; 9():231. PubMed ID: 30050558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
    Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
    Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Variants Are Not Rare in ICD Candidates with Dilated Cardiomyopathy: Time for Next-Generation Sequencing?
    Sousa A; Canedo P; Campelo M; Moura B; Leite S; Baixia M; Belo A; Rocha-Gonçalves F; Machado JC; Silva-Cardoso J; Martins E; Fatima Investigators
    Cardiol Res Pract; 2019; 2019():2743650. PubMed ID: 31179125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.